GSK UK Pharmaceuticals is to change its current Direct to Pharmacy model to a Reduced Wholesaler model from 1 November 2018, with PHOENIX UK being one of three companies selected to distribute GSK’s prescription medicines to community pharmacies, hospitals and dispensing doctors throughout the UK.

Commenting on GSK’s decision Steve Anderson, group managing director PHOENIX UK, said: “GSK’s decision will be warmly welcomed by all our dispensing customers as it will provide them with greater convenience when ordering the GSK prescription medicines they need for their patients.”

Numark managing director Jeremy Meader commented: “This is an historic move by GSK that will ultimately be incredibly positive for community pharmacy.  Times are tough and recognition of the challenges faced by pharmacy by increasing access to a wider range of prescription medicines through PHOENIX will help deliver consistency in service and increase patient loyalty whilst helping them to more effectively and efficiently fulfil their role on the front line of healthcare.”

Recommended

New tool helps Numark members to use NHS data fully

Numark believes the platform will revolutionise the way its members access and use NHS data.

HCP first, business manager second, finds Bayer

More than a third of pharmacists are not comfortable with the selling side of their business, finds Bayer.




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.